A Specific Inhibitory Action of Lithium on the 5-HT2cReceptor Expressed in Xenopus laevis Oocytes
- Departments of 1Public Health (T.M., K.S.) and 2Physiology (T.N.), Kobe University School of Medicine, Kobe 650, Japan.
Abstract
The effect of lithium on the phosphoinositide-signaling pathway was examined in 5-HT2C receptors, which are involved in phospholipase C stimulation, expressed in Xenopus laevisoocytes by voltage-clamp recording and assay of intracellular Ca2+ concentrations. Treatment with lithium for 60 sec after the initial application of 5-HT reduced Ca2+-dependent chloride currents in a dose-dependent manner (0.01–1 mm) and inhibited intracellular Ca2+release, whereas pretreatment with lithium or injection into oocytes had no effect. Additionally, treatment with lithium for more than 24 hr reduced 5-HT-evoked currents to a much lesser extent. In contrast, the currents through other phosphoinositide-dependent receptors, such as endogenous “serum” and muscarinic ACh receptors, were not affected or less affected by a short term or long term treatment with lithium, respectively. These results indicate that lithium may have a specific blocking effect on the 5-HT2C receptors and, in part, nonselectively act on the phosphoinositide metabolic pathway.
Footnotes
-
Send reprint requests to: Dr. Tomoyuki Nishizaki, Department of Physiology, Kobe University School of Medicine, 7–5-1 Kusunoki-cho, Chuo-ku, Kobe 650, Japan.
- Abbreviations:
- 5-HT
- 5-hydroxytryptamine (serotonin)
- ACh
- acetylcholine
- BAPTA
- 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid, tetrapotassium salt, hydrate
- HEPES
- 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
-
- Received July 3, 1996.
- Accepted November 14, 1996.
- The American Society for Pharmacology and Experimental Therapeutics



